Ultragenyx Pharmaceutical Inc(NASDAQ:RARE) 
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. Its biologic products include Crysvita (burosumab), an antibod...
Website: http://www.ultragenyx.com
Founded: 2010
Full Time Employees: 740
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 34.32
H 34.64
L 32.07
C 32.43
V 879,476
10EMA 32.43
20EMA 32.43
60EMA 32.43
120EMA 32.43
250EMA 32.43